Saccharin

CAS No. 81-07-2

Saccharin( —— )

Catalog No. M16028 CAS No. 81-07-2

Flavoring agent and non-nutritive sweetener.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 37 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Saccharin
  • Note
    Research use only, not for human use.
  • Brief Description
    Flavoring agent and non-nutritive sweetener.
  • Description
    Flavoring agent and non-nutritive sweetener. (In Vitro):In vitro, saccharin (0.5, 2.5, 5 mM) inhibits bacterial growth in a species-dependent manner.(In Vivo):In vivo, saccharin (oral; 5 mg/kg; twice a day) intake reduces fecal bacterial load and alters microbiome composition, while the intestinal barrier is not obviously affected in male C57BL/6JRj wild type (wt) mice.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    81-07-2
  • Formula Weight
    183.18
  • Molecular Formula
    C7H5NO3S
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 4,000 mg/L
  • SMILES
    O=C1NS(=O)(=O)C2=CC=CC=C12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Just T, et al. Appetite. 2008 Nov;51(3):622-7.
molnova catalog
related products
  • Antitumor agent-19

    Antitumor agent-19 is an antitumor agent targeting tumor-associated macrophages (TAMs) to serve as an effective TAMs modulator (EC50s: 17.18 μM and 18.87 μM in the RAW 264.7 cells and the BMDM cells).

  • SMS1-IN-1

    SMS1-IN-1 is a potent inhibitor of sphingomyelin synthase 1 (SMS1, IC50 = 2.1 μM), and can be used in the atherosclerosis studies.

  • Disitamab

    Disitamab Vedotin (RC48-0) is a humanized monoclonal antibody that targets HER2 and can be utilized in creating antibody-drug conjugates (ADCs), specifically referred to as Disitamab Vedotin .